Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy

British Journal of Haematology

Volumn 107, Issue 2, 1999, Pages 330-334

  Di Bona, Eros ^a   Rodeghiero, F ^a   Bruno, B ^b   Gabbas, A ^c   Foa, P ^d   Locasciulli, A ^o   Rosanelli, C ^e   Camba, L ^f   Saracco, P ^g   Lippi, A ^h   Iori, A P ^j   Porta, F ^k   De Rossi, V ^l   Comotti, B ^m   Iacopino, P ⁿ   Dufour, C ⁱ   Bacigalupo, A ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Ospedale Civile   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Ospedale Generale   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g Università   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ G GASLINI INSTITUTE   (Italy)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k UNIVERSITY OF BRESCIA   (Italy)

^l BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^m OSPEDALI RIUNITI   (Italy)

ⁿ BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^o NONE

more..

Author keywords

Aplastic anaemia; Cyclosporin; Horse antilymphocyte globulin; Immunosuppressive therapy; Rabbit antithymocyte globulin

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYCLOSPORIN; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANEMIA; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANIMALS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; RABBITS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032734041     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01693.x     Document Type: Article

References (19)

1. Bacigalupo, A., Broccia, A., Corda, G., Arcese, W., Carotenuto, M., Gallamini, A., Locatelli, F., Mori, G.P., Saracco, P., Todeschini, G., Coser, P., Iacopino, P., van Lint, M.T. & Gluckman, E. (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party. Blood, 85, 1348-1353.
2. Bacigalupo, A., Chaple, M., Hows, J., van Lint, M.T., McCann, S., Milligan, D., Chessel, J., Goldstone, A.H., Ottolander, J., van't Veer, E.T., Comotti, B., Coser, P., Broccia, G., Bosi, A., Locasciulli, A., Catalano, M., Battista, R., Arcese, W., Carotenuto, M., Marmont, A.M. & Gordon-Smith, E.C. (1993) Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (Mpred) with or without androgens: a randomized trial for EBMT SAA working party. British Journal of Haematology, 83, 145-151.
3. De Planque. M.M., Bacigalupo, A., Wursh, A., Hows, J.M., Devergie. A., Frickhofen, N., Brand, A. & Nissen, C. (1989) Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. British Journal of Haematology, 73, 121-126.
4. Doney, K., Dahlberg, S.J., Monroe, D., Storb, R., Buckner, C.D. & Thomas, E.D. (1984) Therapy of severe aplastic anemia with antihuman thymocyte globulin and androgens: the effect of HLA haploid identical marrow infusion. Blood, 63, 342-348.
5. Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freun, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. New England Journal of Medicine, 324, 1297-1304.
6. Gluckman, E.. Esperou-Bourdeau, H., Baruchel, A., Booguerts, M., Briere, J., Donadio, D., Leverger, G., Leporrier, M., Reiffers, J., Janvier, M., Michallet, M. & Stryckmans, P. (1992) Multicenter randomized study comparing cyclosporine A alone und antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood, 79, 2540-2546.
7. La Starza, R., Matteucci, C., Crescenzi, B., Criel, A., Selleslag, D., Martelli, M.F., Van den Berghe, H. & Mecucci, C. (1998) Trisomy 6 is the hallmark of a dysplastic clone in bone marrow aplasia. Cancer Genetics and Cytogenetics, 105, 55-59.
8. Marsh, J.C.W., Hows, J.M., Briett, K.A., Al-Hashimi, S., Fairhead, S.M. & Gordon-Smith, E.C. (1987) Survival after antilymphocyte globulin therapy depends on disease severity. Blood, 70, 1046-1052.
9. Means, R.T., Jr. Krantz, S.B., Dessypris, E.N., Luckens, J.N., Niblack, G.D., Greer, J.P., Flexner, J.M. & Stein, R.S. (1988) Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. American Journal of Medicine, 84, 678-682.
10. Mikhailova, N., Sessarego, M., Pugazza, G., Caimo, A., De Filippi, F., van Lint, M.T., Bregante, S., Valeriani, A., Mordini, N.. Lamparelli, T., Gualandi, F., Occhini, D, & Bacigalupo, A. (1996) Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 81, 418-422.
11. Piaggio, G., Podestà, M., Pitto, A., Pittalunga, G.B., Isaza, A., Benvenuto, F., Bruno, B. & Bacigalupo, A. (1998) Comparable TNF-alfa, IFN-gamma and GM-CSF production by purified normal marrow CD3 cells in response to horse antilymphocyte and rabbit antithymocyte globulin. European Journal of Haematology, 60, 240-244.
12. Podestá, M., Piaggio, G., Frassoni, F., Pitto, A.. Zikos, P., Sessarego, M., Abate, M., Van Lint, M.T., Berisso, G,. & Bacigalupo. A. (1998) The assessment of the hematopoietic reservoir after immunosuppressive therapy of bone marrow transplantation in severe aplastic anemia. Blood, 91, 1959-1965.
13. Sehrezenmeier, H., Hinterberger, W., Hows, J., Ljungman, P., Locasciulli, A., Marin, P., Marsh, J., McCann, S., den Ottolander, G.J., Raghavachar, A., Socie, G., Tichelli, A., Van't Veer-Korthof, E.T. & Bacigalupo, A., for the EBMT SAA Working Party (1995) Second immunosuppressive treatment of patients with aplastic anemia not responding to the first course of immunosuppression: a report from the Working Party on severe aplastic anemia of the EBMT. Bone Marrow Transplantation, 15, (Suppl. 1), S10.
14. Schrazenmeier, H., Marin, P., Raghavachar, A., McCann, S., Hows. J., Gluckman, E., Nissen, C., Van't Veer-Korthof, E.T., Ljungman, P., Hinterberger, W., Van Lint, M.T., Frickhofen, N. & Bacigatupo, A. (1993) Relapse of aplastic anaemia after immunosuppressive treatment: a report from European Bone Marrow Transplantation Group SAA Working Party. British Journal of Haematology, 85, 371-377.
15. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Van't Veer-Korthof, E.T. & Gluckman, E., for the European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party (1993) Malignant tumors occurring after treatment of aplastic anemia. New England Journal of Medicine, 329, 1152-1157.
16. Stein, R.S., Means, R.T., Jr. Krantz, S.B., Flexner, J.M. & Greer, J.P. (1994) Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits. American Journal of the Medical Sciences, 308, 338-343.
17. Tichelli, A., Gratwohl, A., Nissen, C., Signer, E,. Stebler Gysi, C. & Speck, B. (1992) Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood, 80, 337-345.
18. Tichelli, A., Passweg, J., Nissen, C., Bargetzi, M., Hoffmann, T., Wodnar-Filipowicz, A., Signer, E., Speck, B. & Gratwohl, A. (1998) Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. British Journal of Haematology, 100, 393-400.
19. Young. N.S. & Macicjewski, J. (1997) The pathophysiology of acquired aplastic anemia. New England Journal of Medicine, 336, 1365-1372.